Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials

REFERENCES

• Friis-Moller N, Sabin CA, Weber R, et al. Combination an-tiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349:1993–2003.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Lewden C, May T, et al. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer 2004;101:317–324.
   PubMed Web of Science ®Google Scholar
• Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with human immunodeficiency virus: the D:A:D Study. Arch Intern Med. 2006;166:1632–1641.
   PubMed Web of Science ®Google Scholar
• The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–2296.
   PubMed Web of Science ®Google Scholar
• Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M. Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS ONE. 2008;3:e1531.
   PubMed Web of Science ®Google Scholar
• Louie JK, Hsu LC, Osmond DH, Katz MH, Schwarcz SK. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998. J Infect Dis. 2002;186:1023–1027.
   PubMed Web of Science ®Google Scholar
• Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med. 2005; 6:99–106.
   PubMed Web of Science ®Google Scholar
• Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J EpidemioL 2005;34:121–130.
   PubMed Web of Science ®Google Scholar
• Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV Outpatient Study. J Acquir Immune Defic Syndr 2006;43:27–34.
   PubMed Web of Science ®Google Scholar
• CASCADE Collaboration. Effective therapy has altered the spectrum of cause-specific mortality following HIV sero-conversion. AIDS. 2006;20:741–749.
   PubMed Web of Science ®Google Scholar
• Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2007; 44:179–187.
   PubMed Web of Science ®Google Scholar
• Phillips A. Morbidity and mortality in the HAART era. Pre-sented at: 15th Conference on Retroviruses and Opportu-nistic Infections; 2008; Boston. Abstract 8.
   Google Scholar
• Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr 2006,41:194–200.
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Statistical Classi-fication of Diseases and Related Health Problems, Volume 2. 2nd ed. Geneva: WHO; 2004:1–125.
   Google Scholar
• CDC. Mortality data, underlying cause-of-death public-use data files. Available at: www.cdc.gov/nchs/products/elec_prods/subject/mortucd.htm.
   Google Scholar
• Ederer F, Geisser MS, Mongin SJ, Church TR, Mandel JS. Colorectal cancer deaths as determined by expert com-mittee and from death certificate: a comparison. The Min-nesota Study. J Clin EpidemioL 1999;52:447–452.
   PubMed Web of Science ®Google Scholar
• Bangdiwala SI, Cohn R, Hazard C, Davis CE, Prineas RJ. Comparisons of cause of death verification methods and costs in the Lipid Research Clinics Program Mortality Follow-Up Study. Control Clin Trials. 1989;10:167–187.
   PubMedGoogle Scholar
• Moy CS, Albert DM, Diener-West M, et al. Cause-specific mortality coding: Methods in the collaborative ocular mela-noma study. Control Clin Trials. 2001;22(3):248–262.
   PubMedGoogle Scholar
• Sesso HD, Gaziano JM, Glynn RJ, Buring JE. Value of an Endpoints Committee versus the use of nosologists for val-idating cause of death. Contemp Clin Trials. 2006;27:333–339.
   PubMed Web of Science ®Google Scholar
• Petersen JL, Hague G, Hellkamp AS, et al. Comparing clas-sifications of death in the Mode Selection Trial: Agreement and disagreement among site investigators and a clinical events committee. Contemp Clin Trials. 2006;27:260–268.
   PubMed Web of Science ®Google Scholar
• Emery S, Abrams DI, Cooper DA, et al. The Evaluation of Subcutaneous Proleukin (interleukin-2) in a Randomized International Trial: Rationale, design, and methods of ES-PRIT. Control Clin Trials. 2002;23:198–220.
   PubMedGoogle Scholar
• Levy Y, Mitsuyasu R, Tambusi G, et al. CD4 count increases in patients with CD4 counts of 50–300 treated with inter-mittent IL-2: Immunologic results from the Study of IL-2 in Combination with Active Antiretroviral Therapy (SILCAAT) Trial. Presented at: Ninth European AIDS Conference; 2003; Warsaw. Abstract F 14/3.
   Google Scholar
• Olsen CH, Friis-Moller N, d'Arminio Monforte A, et al. Pilot of the CoDe (Coding of Death) project-a standardized approach to code causes of death in HIV infected individu-als. Presented at: 10th European AIDS Conference; 2005; Dublin. Abstract PE18.4/9.
   Google Scholar
• Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded sur-veillance case definition for AIDS among adolescents and adults. MMWR. 1992:41(RR-17):1–19.
   Google Scholar
• Coady SA, Sorlie PD, Cooper LS, et al. Validation of death certificate diagnosis for coronary heart disease: The Ath-erosclerosis Risk in Communities (ARIC) Study. J Clin Epi-demioL 200154: 40–50.
   Google Scholar
• Myers KA, Farquhar DR. Improving the accuracy of death certification. CMAJ. 1998; 158:1317–1323.
   PubMed Web of Science ®Google Scholar
• Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001161: 277–284.
   Google Scholar
• Ravakhah K. Death certificates are not reliable: revivifica-tion of the autopsy. Southern Med J. 2006;99:728–733.
   PubMed Web of Science ®Google Scholar
• Lifson AR, Rhame FS, Belloso WH, et al. Reporting and evaluation of HIV-related clinical endpoints in two mul-ticenter international clinical trials. HIV Clin Trials. 2006; 7:125–141.
   PubMed Web of Science ®Google Scholar
• Mahaffey KW, Harrington RA, Akkerhuis M, et al. Dis-agreements between central clinical events committee and site investigator assessments of myocardial infarc-tion end-points in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med. 2001;2: 187–194.
   PubMedGoogle Scholar
• Mahaffey KW, Roe MT, Dyke CK, et al. Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Am Heart J. 2002;143:242–248.
   PubMed Web of Science ®Google Scholar
• Naslund U, Grip L, Fischer-Hansen J, et al. The impact of an end-point committee in a large, multicentre, random-ized, placebo-controlled clinical trial. Eur Heart J. 1999; 20:771–777.
   PubMed Web of Science ®Google Scholar
• Eisenbud R, Assmann SF, Kalish LA, et al. Differences in difficulty adjudicating clinical events in patients with ad-vanced HIV disease. J Acquir Immune Defic Syndr 2001; 28:43–46.
   PubMed Web of Science ®Google Scholar
• Walter SD, Cook DJ, Guyatt GH, et al. Outcome assess-ment for clinical trials: How many adjudicators do we need? Controlled Clin Trials. 1997;18:27-42.
   Google Scholar
• Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individu-als. Cancer 2005;104:1505–1511.
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Inci-dence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007:370:59–67.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Pfeiffer RM, Chang L, et al. Elevated risk of lung cancer among people with AIDS. AIDS. 2007;21:207–213.
   PubMed Web of Science ®Google Scholar
• Kirk GD, Merlo C, O'Driscoll P, et al. HIV infection is associ-ated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007;45:103–110.
   PubMed Web of Science ®Google Scholar
• Engels EA, Brock MV, Chen J, et al. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006;24:1383–1388.
   PubMed Web of Science ®Google Scholar
• The DAD Study Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356: 1723–1735.
   PubMed Web of Science ®Google Scholar
• Kamin DS, Grinspoon SK. Cardiovascular disease in HIV-positive patients. AIDS. 2005;19: 641–652.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634–2653.
   PubMed Web of Science ®Google Scholar
• Jain MK, Skiest DJ, Cloud JW, et al. Changes in mortality related to human immunodeficiency virus infection: comparative analysis of inpatient deaths in 1995 and in 1999-2000. Clin Infect Dis. 2003;36:1030–1038.
   PubMed Web of Science ®Google Scholar
• Eyster ME. Diamondstone LS, Lien JM, et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immuno-deficiency virus. J Acquire Immune Defic Syndr. 1993; 6:602–610.
   PubMed Web of Science ®Google Scholar
• Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hep-atitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33:562–569.
   PubMed Web of Science ®Google Scholar
• Thio CL, Seaberg EC, Skolasky R, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet. 2002;360:1921–1926.
   PubMed Web of Science ®Google Scholar
• Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19:593–601
   PubMed Web of Science ®Google Scholar
• Hirschtick RE, Glassroth J, Jordan MC, et al. Bacterial pneumonia in persons infected with the human immuno-deficiency virus. N Engl J Med. 1995;333:845–851.
   PubMed Web of Science ®Google Scholar
• Kohli R, Lo Y, Homel Petal. Bacterial pneumonia, HIV ther-apy, and disease progression among HIV-infected women in the HIV Epidemiologic Research (HER) Study. Clin Infect Dis. 2006;43:90–98.
   PubMed Web of Science ®Google Scholar
• Lyon R, Hague AK, Asmuth DM, Woods GL. Changing patterns of infections in patients with AIDS: A study of 279 autopsies of prison inmates and nonincarcerated patients at a university hospital in eastern Texas, 1984-1993. Clin Infec Dis. 1996;23:241–247.
   PubMed Web of Science ®Google Scholar
• Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immuno-deficiency virus: A case-control study of risk factors and outcomes. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:51–57.
   PubMedGoogle Scholar
• Carrico AW, Johnson MO, Morin SF, et al. Correlates of suicidal ideation among HIV-positive persons. AIDS. 2007; 21:1199–1203.
   PubMed Web of Science ®Google Scholar
• Robertson K, Parsons TD, van der Horst C, Hall C. Thoughts of death and suicidal ideation in nonpsychiatric human immunodeficiency virus seropositive individuals. Death Studies. 2006;30:455–469.
   PubMed Web of Science ®Google Scholar
• Angelino AF, Treisman GJ. Management of psychiatric dis-orders in patients infected with human immunodeficiency virus. Clin Infect Dis. 2001;33:847–856.
   PubMed Web of Science ®Google Scholar
• Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS. 2005;19:2057–2067.
   PubMed Web of Science ®Google Scholar
• Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis. 2007;45: 241–249.
   PubMed Web of Science ®Google Scholar
• Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007;21:713–719.
   PubMed Web of Science ®Google Scholar